blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2727943

EP2727943 - Trispecific antibodies against human EGFR, HER2 and HER3 [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  01.05.2015
Database last updated on 24.07.2024
Most recent event   Tooltip01.05.2015Application deemed to be withdrawnpublished on 03.06.2015  [2015/23]
Applicant(s)For all designated states
MAB Discovery GmbH
Forstenrieder Strasse 8-14
82061 Neuried / DE
[2014/19]
Inventor(s)01 / Fischer, Stephan
Alpspitzstrasse 1
82362 Weilheim / DE
02 / Renninger, Stephanie
Portenstrasse 19
81379 München / DE
 [2014/19]
Representative(s)Schreiner, Siegfried
Finkenweg 1
82362 Weilheim / DE
[2014/19]
Application number, filing date12007506.405.11.2012
[2014/19]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP2727943
Date:07.05.2014
Language:EN
[2014/19]
Search report(s)(Supplementary) European search report - dispatched on:EP12.04.2013
ClassificationIPC:C07K16/28, C07K16/32, C07K16/00
[2014/19]
CPC:
C07K16/2863 (EP); C07K16/32 (EP); C07K2317/33 (EP)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2014/19]
Extension statesBANot yet paid
MENot yet paid
TitleGerman:Trispezifische Antikörper gegen menschliche EGFR, HER2 und HER3[2014/19]
English:Trispecific antibodies against human EGFR, HER2 and HER3[2014/19]
French:Anticorps trispécifique contre le EGFR, HER2 et HER3 humains[2014/19]
Examination procedure08.11.2014Application deemed to be withdrawn, date of legal effect  [2015/23]
18.12.2014Despatch of communication that the application is deemed to be withdrawn, reason: examination fee not paid in time  [2015/23]
Fees paidPenalty fee
Additional fee for renewal fee
30.11.201403   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[A]WO2010108127  (GENENTECH INC [US], et al) [A] 1-12 * page 4, lines 29-31 * * page 32, line 30 - page 33, line 21 * * page 6, lines 17-24 * * page 35, lines 28-30 *;
 [A]WO03012072  (UNIV PENNSYLVANIA [US], et al) [A] 1-12 * page 2, lines 26-30 * * page 10, line 26 - page 11, line 2 * * page 55, lines 12-16 *;
 [XY]WO9964461  (GENENTECH INC [US]) [X] 1,6-9 * abstract * * page 3, lines 1-25 * * page 4, lines 34-36 * * page 17, lines 1-4 * * page 19, lines 1-4 * * page 40; table 2 * * page 35, lines 14-23; example 2 * [Y] 2-5,10-12;
 [YA]WO2007056411  (GENENTECH INC [US], et al) [Y] 2-5 * abstract * * page 2, lines 4-10 * * page 3, lines 15-25 * * page 5, lines 15-18 * * page 39, lines 12-17 * * page 40, lines 7-14 * * page 43; table 1 * * figures 5,6 * [A] 1,6-12
 [A]  - SCHAEFER GABRIELE ET AL, "A Two-in-One Antibody against HER3 and EGFR Has Superior Inhibitory Activity Compared with Monospecific Antibodies", CANCER CELL, (201110), vol. 20, no. 4, pages 472 - 486, XP002694584 [A] 1-12 * abstract *

DOI:   http://dx.doi.org/10.1016/j.ccr.2011.09.003
 [A]  - KOENIG PATRICK ET AL, Two-in-One Antibodies, BISPECIFIC ANTIBODIES, SPRINGER-VERLAG BERLIN HEIDELBERG, GERMANY, PAGE(S) 187 - 198, (20110101), ISBN 978-3-642-20909-3, XP008156629 [A] 1-12 * page 188, paragraph 2 * * page 189 - page 195 * * page 196 *

DOI:   http://dx.doi.org/10.1007/978-3-642-20910-9_11
 [A]  - FAGETE SEVERINE ET AL, "Smarter Drugs A Focus on Pan-Specific Monoclonal Antibodies", BIODRUGS: CLINICAL IMMUNOTHERAPEUTICS, BIOPHARMACEUTICALS AND GENE THERAPY, ADIS INTERNATIONAL, FR, (20110101), vol. 25, no. 6, doi:10.2165/11594690-000000000-00000, ISSN 1173-8804, pages 357 - 364, XP009157143 [A] 1-12 * abstract * * page 359, column l, paragraph 2 - page 360 * * page 360, column r *

DOI:   http://dx.doi.org/10.2165/11594690-000000000-00000
 [YA]  - KUSI KWADWO A ET AL, "Immunization with different PfAMA1 alleles in sequence induces clonal imprint humoral responses that are similar to responses induced by the same alleles as a vaccine cocktail in rabbits", MALARIA JOURNAL, BIOMED CENTRAL, LONDON, GB, (20110214), vol. 10, no. 1, doi:10.1186/1475-2875-10-40, ISSN 1475-2875, page 40, XP021088221 [Y] 2-5,10-12 * abstract * * page 41, column l, paragraph 3 * * page 41, column r, paragraph 2 * [A] 1,6-9

DOI:   http://dx.doi.org/10.1186/1475-2875-10-40
 [YA]  - KUSI KWADWO A ET AL, "Humoral Immune Response to Mixed PfAMA1 Alleles; Multivalent PfAMA1 Vaccines Induce Broad Specificity", PLOS ONE, (200912), vol. 4, no. 12, ISSN 1932-6203, XP002694585 [Y] 2-5,10-12 * abstract * * page 2, column r, paragraph 1 * [A] 1,6-9

DOI:   http://dx.doi.org/10.1371/journal.pone.0008110
 [YA]  - MALHERBE DELPHINE C ET AL, "Sequential Immunization with a Subtype B HIV-1 Envelope Quasispecies Partially Mimics the In Vivo Development of Neutralizing Antibodies", JOURNAL OF VIROLOGY, (201106), vol. 85, no. 11, pages 5262 - 5274, XP002694586 [Y] 2-5,10-12 * abstract * [A] 1,6-9

DOI:   http://dx.doi.org/10.1128/JVI.02419-10
 [A]  - FISCHER N, "New magic bullets can hit more than one target", EXPERT OPINION ON DRUG DISCOVERY, INFORMA HEALTHCARE, LONDON, GB, (20080101), vol. 3, no. 8, ISSN 1746-0441, pages 833 - 839, XP008144459 [A] 1-12 * page 836, column l, paragraph 2 - page 837, column l, paragraph 2 * * page 837, column l, paragraph 3 * * table 1 *
by applicantWO9964461
 WO9939729
 WO2008027236
 WO2007146959
 WO2008140493
 WO2010129304
 WO2010108127
 WO2011056997
 WO2011060206
 WO2011140254
 WO2012007167
 US5202238
 US5204244
 US6602684
 WO2005044859
 WO2004065540
 WO2007031875
 WO2011147903
 WO2007003041
 WO2008045140
 WO2004106377
 EP1255780
 EP1633787
 EP0488470
    - FENDRY BM. ET AL., CANCER RES., (1990), vol. 50, pages 1550 - 1558
    - BOSTROM J. ET AL., SCIENCE, (2009), vol. 323, pages 1610 - 1614
    - BOSTROM J. ET AL., PLOS, (2011), page E17887
    - SCHAEFER G. ET AL., CANCER CELL, (2011), vol. 20, page 472
    - WEDEMAYER GJ ET AL., SCIENCE, (19970613), vol. 276, no. 5319, pages 1665 - 9
    - HUSTON, J.S., METHODS IN ENZYMOL., (1991), vol. 203, pages 46 - 88
    - MORRISON, S.L. ET AL., PROC. NATL. ACAD. SCI. USA, (1984), vol. 81, pages 6851 - 6855
    - RIECHMANN, L. ET AL., NATURE, (1988), vol. 33.2, pages 323 - 327
    - NEUBERGER, M.S. ET AL., NATURE, (1985), vol. 314, pages 268 - 270
    - KONTERMANN R., MABS, (20120301), vol. 4, no. 2
    - CARAVELLA J; LUGOVSKOY, A., CURR OPIN CHEM BIOL., (201008), vol. 14, no. 4, pages 520 - 8
    - JOHNSON, G.; WU, T.T., NUCLEIC ACIDS RES., (2000), vol. 28, pages 214 - 218
    - MARKS ET AL., BIO/TECHNOLOGY, (1992), vol. 10, pages 779 - 783
    - BARBAS ET AL., PROC NAT. ACAD. SCI, USA, (1994), vol. 91, pages 3809 - 3813
    - SCHIER ET AL., GENE, (1995), vol. 169, pages 147 - 155
    - YELTON ET AL., J. IMMUNOL., (1995), vol. 155, pages 1994 - 2004
    - JACKSON ET AL., J. IMMUNOL., (1995), vol. 1 54, no. 7, pages 3310 - 9
    - HAWKINS ET AL., J. MOL. BIOL., (1992), vol. 226, pages 889 - 896
    - UMANA, P. ET AL., NATURE BIOTECHNOL., (1999), vol. 17, pages 176 - 180
    - MAKRIDES, S.C., PROTEIN EXPR. PURIF., (1999), vol. 17, pages 183 - 202
    - GEISSE, S. ET AL., PROTEIN EXPR. PURIF., (1996), vol. 8, pages 271 - 282
    - KAUFMAN, R.J., MOL. BIOTECHNOL., (2000), vol. 16, pages 151 - 161
    - WERNER, R.G., DRUG RES., (1998), vol. 48, pages 870 - 880
    - BARNES, L.M. ET AL., CYTOTECHNOLOGY, (2000), vol. 32, pages 109 - 123
    - BARNES, L.M. ET AL., BIOTECH. BIOENG., (2001), vol. 73, pages 261 - 270
    - DUROCHER, Y. ET AL., NUCL. ACIDS. RES., (2002), vol. 30, page E9
    - ORLANDI, R. ET AL., PROC. NATL. ACAD. SCI. USA, (1989), vol. 86, pages 3833 - 3837
    - CARTER, P. ET AL., PROC. NATL. ACAD. SCI. USA, (1992), vol. 89, pages 4285 - 4289
    - NORDERHAUG, L. ET AL., J. IMMUNOL. METHODS, (1997), vol. 204, pages 77 - 87
    - SCHLAEGER, E.-J.; CHRISTENSEN, K., CYTOTECHNOLOGY, (1999), vol. 30, pages 71 - 83
    - SCHLAEGER, E.-J., J. IMMUNOL. METHODS, (1996), vol. 194, pages 191 - 199
    - KRUPKE DM; BEGLEY DA; SUNDBERG JP; BULT CJ; EPPIG JT, "The Mouse Tumor Biology database", NAT REV CANCER, (200806), vol. 8, no. 6, pages 459 - 65
    - KODITUWAKKO AP ET AL., IMMUNOL. CELL BIOL., (2003), vol. 81, pages 163 - 170
    - ZUBLER, R.H. ET AL., EUR. J. IMMUNOL., (1984), vol. 14, pages 357 - 63
    - WEN L. ET AL., EUR. J. IMMUNOL., (1987), vol. 17, pages 887 - 92
    - HOFFMANN P ET AL., J IMMUNOL. METHODS, (1996), vol. 196, no. 1, pages 85 - 91
    - ROY A. ET AL., J HEMATOTHER. STEM CELL RES., (2001), vol. 10, no. 6, pages 873 - 80
    - DLU A. ET AL., PROC. NATI. ACAD. SCI. USA, (1987), vol. 84, pages 9140 - 9144
    - WILDT RM; HOET RM., METHODS MOL. BIOL., (2002), vol. 178, pages 121 - 31
    - METHODS IN ENZYMOLOGY, ACADEMIC PRESS, INC.
    - L. WEN ET AL., EUR. J. IMMUNOL., (1987), vol. 17, pages 887 - 892
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.